| Dr Amanda Lynn Beery, MD | |
|
3260 Providence Dr, Ste 322, Anchorage, AK 99508-4661 | |
| (907) 563-5151 | |
| (907) 563-6278 |
| Full Name | Dr Amanda Lynn Beery |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 3260 Providence Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861784407 | NPI | - | NPPES |
| 1631901 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 102191 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Womens Health Pc | 7012090210 | 11 |
News Archive
Advanced practice clinicians, such as nurse practitioners and physician assistants, are 34 percent more likely than primary care physicians to prescribe an imaging exam for patients, according to a Harvey L. Neiman Health Policy Institute study published in JAMA Internal Medicine.
Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50 in developed countries. Although this condition affects up to 20% of people between the ages of 65 and 75, what drives abnormal blood vessels to invade the retina is unknown.
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.
Researchers have discovered a new link between broken-heart syndrome, or takotsubo syndrome, and the second leading cause of death in the world: cancer.
A research team at Penn State has developed a novel method for attaching small molecules, such as neurotransmitters, to surfaces, which then are used to capture large biomolecules.
› Verified 6 days ago
| Entity Name | Alaska Womens Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083890180 PECOS PAC ID: 7012090210 Enrollment ID: O20080212000034 |
News Archive
Advanced practice clinicians, such as nurse practitioners and physician assistants, are 34 percent more likely than primary care physicians to prescribe an imaging exam for patients, according to a Harvey L. Neiman Health Policy Institute study published in JAMA Internal Medicine.
Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50 in developed countries. Although this condition affects up to 20% of people between the ages of 65 and 75, what drives abnormal blood vessels to invade the retina is unknown.
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.
Researchers have discovered a new link between broken-heart syndrome, or takotsubo syndrome, and the second leading cause of death in the world: cancer.
A research team at Penn State has developed a novel method for attaching small molecules, such as neurotransmitters, to surfaces, which then are used to capture large biomolecules.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda Lynn Beery, MD 3260 Providence Dr, Ste 322, Anchorage, AK 99508-4661 Ph: (907) 563-5151 | Dr Amanda Lynn Beery, MD 3260 Providence Dr, Ste 322, Anchorage, AK 99508-4661 Ph: (907) 563-5151 |
News Archive
Advanced practice clinicians, such as nurse practitioners and physician assistants, are 34 percent more likely than primary care physicians to prescribe an imaging exam for patients, according to a Harvey L. Neiman Health Policy Institute study published in JAMA Internal Medicine.
Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50 in developed countries. Although this condition affects up to 20% of people between the ages of 65 and 75, what drives abnormal blood vessels to invade the retina is unknown.
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.
Researchers have discovered a new link between broken-heart syndrome, or takotsubo syndrome, and the second leading cause of death in the world: cancer.
A research team at Penn State has developed a novel method for attaching small molecules, such as neurotransmitters, to surfaces, which then are used to capture large biomolecules.
› Verified 6 days ago
Dr. Wendy Sue Cruz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2741 Debarr Rd Ste C205, Anchorage, AK 99508 Phone: 907-279-2273 Fax: 907-258-7705 | |
Dr. James Thomas Barber Jr., D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3831 Piper St Ste Sll020, Anchorage, AK 99508 Phone: 907-212-3470 Fax: 907-212-3474 | |
Dr. Natalie Dawn Ward, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, Ste. #425, Anchorage, AK 99508 Phone: 907-561-7111 Fax: 907-770-7891 | |
Tania H Hall, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, Ste 322, Anchorage, AK 99508 Phone: 907-563-5151 Fax: 907-563-6278 | |
Anne Gray, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4141 Ambassador Dr, Anchorage, AK 99508 Phone: 907-729-1542 | |
Mrs. Kristin M Murray, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4115 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-563-7228 Fax: 907-563-6278 | |
Kathryn Murphy, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-3116 |